Delivery Order SPE2DB20D3101-SPE2DB22FK2C6
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $21,407.33. The contract has a period of performance through March 1, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 syringes (0.5 mL) and has a ceiling value of $11,186.94. The contract is a firm fixed-price contract, and the ultimate completion date is September 22, 2023. This contract is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $7,319.22 and a period of performance through January 24, 2024. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen, as a major pharmaceutical distributor, has a significant...
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of PREVNAR 13 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The award, valued at $114,576.84, is a delivery order contract with a firm fixed price. The contract has a performance period ending on March 31, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of PREVNAR 13 Syringes, 0.5 mL, with a ceiling value of $2,575.04. The award has a final completion date of February 6, 2024 and is a Firm Fixed Price contract type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of PREVNAR 13 SYRINGE 0.5ML medical supplies. The contract has a ceiling value of $6,414.17 and an ultimate completion date of April 25, 2023. This award falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC...
- This federal contract award, valued at $13,837.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with a completion date of January 30, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $4,112.99, to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Prevnar 13 syringes (0.5 mL) and has a completion date of November 8, 2022. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREVNAR 13 syringes, a vaccine product, with a ceiling value of $8,394.54 and an ultimate completion date of April 18, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 13 SYRINGE 0.5ML. The contract has a ceiling value of $109,120.80 and an ultimate completion date of October 25, 2022. The contract type is Firm Fixed Price, and it was not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK2C6Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes with a 0.5 ml dosage. The contract has a ceiling value of $57,429.95 and an ultimate completion date of June 24, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.4k | 6/23/22 |